News and Treatment Updates

Here's where you'll find a regularly updated, broad range of articles written by the AAMDSIF team, allied health organizations and news organizations. By staying well-informed, patients and families are practicing a form of self-support that will help them be more effective self-advocates when engaging with health care providers.

Stuck Inside? Come Hang Out With The Mighty Community!

Original Publication Date
Article Source
External Web Content
Join The Mighty’s staff and community for a series of events designed to put the SOCIAL in social distancing. We’ve got writing workshops, fun events for kids, interactive Facebook Lives, and more! Check out the schedule (con't)

Expanded Choices Emerge for Myelofibrosis Following Ruxolitinib Therapy

Original Publication Date
Article Source
External Web Content
Ruben Mesa, MD Newly approved and investigational agents are joining ruxolitinib (Jakafi) for the treatment of myelofibrosis (MF) and may provide options for patients who progress or become intolerant to frontline JAK inhibitors. At the 24th Annual International Congress on…

OncLive Peer Exchange: Diagnosis of Myelodysplastic Syndrome

Original Publication Date
Article Source
External Web Content
The panel provides perspective on the diagnosis of MDS, or Myelodysplastic Syndromes. They discuss recent innovation, including next-gen testing to enhance the efficacy of treatments. Watch these experts here!

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

Original Publication Date
Article Source
External Web Content
Abstract BACKGROUND Patients with anemia and lower-risk myelodysplastic syndromes in whom erythropoiesis-stimulating agent therapy is not effective generally become dependent on red-cell transfusions. Luspatercept, a recombinant fusion protein that binds transforming growth…

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.

We Recommend

For Patients and Families